Please cite this article as: Garg S et al., Treatment emergent affective switch with intermittent theta burst stimulation over right temporo-parietal junction: A case report, Brain Stimulation, https://doi.
A Small, yet notable, risk of treatment emergent affective switch (TEAS) is associated with the use of repetitive transcranial magnetic stimulation (rTMS) for treatment of both unipolar and bipolar depression [1, 2] . We report the case of a 42-year-old female, diagnosed with major depressive disorder (recurrent) and psychogenic non epileptic seizures (PNES), who showed TEAS with intermittent theta burst stimulation (iTBS). She presented with an episode of low mood, vague pain symptoms such as headache, reduced interest, easy fatigability, disturbed sleep and impaired activities of daily living for one month. During this episode, she also had brief paroxysms of anxiety associated with sudden stiffening of the arms and legs clenching of teeth and unresponsiveness, each lasting about 10 minutes. All these paroxysms occurred at home, in the presence of family members, either while lying on bed or sitting down. These attacks were not associated with tongue bite, physical injury or incontinence. There was no history of bipolar disorder or epilepsy in family members. MRI Brain and video EEG were unremarkable. Over the past 2 years, she had 2 similar episodes of depression with PNES, each lasting for a month. These episodes had resolved completely with a combination of mirtazapine (15mg/day), flupentixol (0.5mg/day) and clonazepam (0.5mg/day). However, in view of the inadequate response to the same regimen for 3 weeks during the current episode, she was offered adjunctive rTMS. The doses of the medications remained the same.
rTMS was delivered using MagVenture-MagPro-R30 device with a figure-of-8 shaped coil. In view of the prominent PNES, excitatory stimulation over right temporoparietal junction (rTPJ, 1 cm lateral to CP4 electrode in the 10e20 international EEG system) was given [3] . Stimulation was delivered using iTBS administered at 80% resting motor threshold (RMT), which was determined prior to stimulation sessions. She was scheduled to receive 10 rTMS sessions (2 sessions/day) with 600 pulses per session over a period of 7 days. Stimulation parameters and duration of treatment were in accordance with safety guidelines prescribed for TBS. This protocol was approved by the Institute's ethics committee (Reference.no. SGRR/IEC/13/18, IEC Registration No. ECR/710/Inst/UK/2015/RR-18).
Her baseline scores on the Hamilton depression rating scale (HDRS) and the PNES scale were 18 and 22, respectively. She started showing significant improvement in depressive symptoms, sleep and PNES by third session of rTMS. However, by 5th session, she was noted to be overfamiliar, euphoric and talking excessively; her HDRS, PNES and Young mania rating scale (YMRS) scores were 3, 13 and 18, respectively. rTMS was stopped immediately, but her medications were continued at same doses. Three days after stopping the rTMS, YMRS scores reduced to 14, however, HDRS and PNES scale scores remained at 3 and 13, respectively. On day-10 post rTMS, scores on HRDS, PNES scale and YMRS were 6, 1 and 12, respectively. At one month follow-up, patient was asymptomatic on the oral drug regime.
TEAS associated with iTBS, which is proposed as an alternative mode of rTMS in the treatment of depression [4] , has not been reported so far [5] . TEAS has been reported with use of both low (1e5 Hz) and high frequency (10Hz) rTMS over right as well as left dorsolateral prefrontal cortices (DLPFC) [1, 2] . However, neurobiological mechanisms underlying TEAS with rTMS are poorly characterized. Of the several neurobiological hypotheses proposed to describe antidepressant related TEAS [6] , glutaminergic model appears most relevant to understand the mechanism of rTMS action [7] . rTMS is considered to have an integrative mode of action through modulation of neuronal pathways functionally connected with the target area [8] . Interestingly, functional connectivity disruption in rTPJ, especially with DLPFC -the conventional target for rTMS in depression, has been proposed to have a major pathophysiological role in depression [9, 10] . Considering the recent increase in interest to investigate rTPJ as a potential target for depression, TEAS associated with its excitation needs to be borne in mind as a potential significant adverse event.
